Our Story
At 4TEEN4 we are committed to advancing critical care management to provide therapeutic solutions to patients in critical stages. We are relying on our scientific expertise and technology to drive innovations. Our team is tackling one of the leading causes of death worldwide and one of the most common reasons for ICU admission. We aim at addressing the rising unmet medical needs in critical care to ultimately help critically ill patients.
- 4TEEN4 headquarter is located in Hennigsdorf near Berlin, Germany
- 4TEEN4 subsidiary is located in the biomedical technology cluster RWTH Aachen campus.
Management
Dr. Andreas Bergmann
A serial entrepreneur having founded and co-founded more than 10 companies. He has been active in the biotechnology industry for over 25 years and has been leading the discovery and routine adoption of important blood biomarkers, as well as...
read moreDr. Karine Bourgeois
More than 13 years of experience in R&D of small molecule and antibody therapies as well as biomarker development. She is an author of more than 30 peer-reviewed scientific publications and a recipient of over 7 awards, including the presti...
read moreBecome part of the TEAM
JOBS